시간 외 거래: 20.92

Syndax Pharmaceuticals Inc (SNDX)

Syndax Pharmaceuticals Inc 주식(SNDX)의 최신 뉴스

Syndax Pharmaceuticals Inc (SNDX)

Syndax Pharmaceuticals Inc 주식(SNDX)의 최신 뉴스

Can you now get a good deal on Syndax Pharmaceuticals Inc's shares? – US Post News - US Post News

Syndax appoints Aleksandra Rizo to board of directors - Investing.com Canada

Syndax Pharmaceuticals Welcomes New Board Member, Passes Resolutions - TipRanks.com - TipRanks

Ratio Revelations: Syndax Pharmaceuticals Inc (SNDX)'s Financial Metrics in the Spotlight – DWinneX - The Dwinnex

New York State Common Retirement Fund Sells 1842 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

(SNDX) Trading Advice - Stock Traders Daily

Syndax Pharmaceuticals, Inc. Forecasted to Earn Q2 2024 Earnings of ($0.96) Per Share (NASDAQ:SNDX) - MarketBeat

There is no way Syndax Pharmaceuticals Inc (SNDX) can keep these numbers up – Sete News - SETE News

Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Increased to $40.00 by Analysts at Stifel Nicolaus - Defense World

Syndax Pharmaceuticals (NASDAQ:SNDX) Given “Buy” Rating at HC Wainwright - Defense World

B. Riley Equities Analysts Boost Earnings Estimates for Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript - Insider Monkey

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript - Yahoo Finance

Syndax Pharmaceuticals (SNDX) Stock Forecast and Price Target 2024 - MarketBeat

Are Medical Stocks Lagging Acer Therapeutics (ACER) This Year? - Yahoo Lifestyle Australia

Cwm LLC Buys 1358 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Citigroup Lowers Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target to $30.00 - MarketBeat

Syndax Pharmaceuticals (NASDAQ:SNDX) Given New $40.00 Price Target at Stifel Nicolaus - MarketBeat

Syndax Pharmaceuticals (NASDAQ:SNDX) Posts Quarterly Earnings Results - MarketBeat

Syndax Pharmaceuticals (NASDAQ:SNDX) Rating Reiterated by HC Wainwright - MarketBeat

Syndax Pharmaceuticals stock target raised by Stifel By Investing.com - Investing.com Canada

Here's Why Momentum in Syndax (SNDX) Should Keep going - Yahoo Movies UK

Syndax Announces Participation at the Bank of America Securities 2024 Health Care Conference - PrimePublishers.com

Syndax Pharmaceuticals (SNDX) Outpaces Stock Market Gains: What You Should Know - Yahoo Singapore News

Have Insiders Been Buying Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares This Year? - Yahoo Movies Canada

(SNDX) Investment Analysis and Advice - Stock Traders Daily

Syndax Pharmaceuticals (SNDX) Gains But Lags Market: What You Should Know - Yahoo Movies Canada

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Investing.com India

Syndax Pharmaceuticals (SNDX) Set to Announce Quarterly Earnings on Wednesday - MarketBeat

Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates

Ratio Review: Analyzing Syndax Pharmaceuticals Inc (SNDX)'s Price-to-Cash and Price-to-Free Cash Flow – DWinneX - The Dwinnex

Ratio Review: Analyzing Syndax Pharmaceuticals Inc (SNDX)'s Price-to-Cash and Price-to-Free Cash Flow – DWinneX - The Dwinnex

Syndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology Forum - Investing.com South Africa

Crinetics, Syndax stocks gain amid pitch at Sohn charity conference (NASDAQ:CRNX) - Seeking Alpha

Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA

SNDX Stock Quote Price and Forecast - CNN

Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA - Yahoo Finance

Syndax Pharmaceuticals Welcomes New CCO Steven Closter - TipRanks.com - TipRanks

Here's Why We're Not Too Worried About Syndax Pharmaceuticals' (NASDAQ:SNDX) Cash Burn Situation - Yahoo Finance

5 Biotech Stocks with Huge Potential - Insider Monkey

Syndax (SNDX) is on the Move, Here's Why the Trend Could be Sustainable

Incyte's (INCY) Q4 Earnings & Revenues Fall Shy of Estimates

Biotech Is Ripe for M&A. These May Be the Next Acquisition Targets. - Barron's

Syndax Revumenib effect R/R KMT2A-rearranged acute leukaemia - Clinical Trials Arena

With 85% ownership of the shares, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is heavily dominated by ... - Yahoo Finance

What's Going On With Leukemia-Focused Syndax Pharmaceuticals (SNDX) Stock Today? - Syndax Pharmaceuticals - Benzinga

Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab ... - Business Wire

Syndax Pharmaceuticals Inc (SNDX) Reports Q3 2023 Financial Results - Yahoo Finance

Ahead in menin inhibitor race, Syndax plans FDA filing in high-risk leukemias this year - BioWorld Online

We Think Syndax Pharmaceuticals (NASDAQ:SNDX) Can Afford To Drive Business Growth - Yahoo Finance

SNDX과 유사한 종목